MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

Clinical trial NCT07075471 · RECRUITING

Trial details

NCT number: NCT07075471
Sponsor: Deciphera Pharmaceuticals, LLC
Status: RECRUITING
Study type: OBSERVATIONAL

Tenosynovial Giant Cell Tumor

Start date: 2025-09-03
Primary completion: 2027-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.